SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: blankmind who wrote (4262)1/4/1998 3:23:00 AM
From: RT  Read Replies (1) | Respond to of 23519
 
blankmind,

Tonight on the nightly news, WGNX/CBS in Atlanta, GA. did a five minute news segment on ED. They discussed and showed Caverjack, Muse and Viagara. It was a nicely done piece.
I believe the Dr. who discussed the products was either named Dr. Greco or Dr. Garcia.

RT



To: blankmind who wrote (4262)1/4/1998 4:03:00 AM
From: Evan Dimmer  Read Replies (2) | Respond to of 23519
 
OK-

I am certainly no doctor, and definitely have no experience with MUSE, so could someone please translate the second half of this statement taken from the 10-Q, in terms a non-doctor would understand? What is the difference between MUSE and the "second product candidate"? What does the prazosin add?

The Company has sought and will continue to seek additional pharmacologic agents for the treatment of erectile dysfunction that are suitable for transurethral delivery for which significant safety data already exists. The Company believes that such agents may progress rapidly through clinical development and the regulatory process due to the preexisting safety data. The Company expects to begin a Phase III multi-center trial in the first half of 1998 for its second product candidate, a combination of alprostadil and prazosin delivered via the Company's transurethral system for erection. The Company has several other product candidates in preclinical development.

Thanks

Ed



To: blankmind who wrote (4262)1/4/1998 6:04:00 PM
From: MIKE DUBIS  Respond to of 23519
 
blankmind: the shorts aren't going to need shares to cover a stock that is going nowhere soon. 16 is the top; 8 likely before 16.

Again, only my opinion


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News